At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Size Sorted Ascending View  
4 neff, p sherrill Jun 7, 2007 34.6 KB View HTML View PDF View XLS  
3 weinhoff gregory m May 30, 2007 31.8 KB View HTML View PDF View XLS  
4 topper, james n Jun 29, 2007 33.2 KB View HTML View PDF View XLS  
4 topper, james n Feb 4, 2008 35.0 KB View HTML View PDF View XLS  
4 frazier, healthcare iv lp Feb 14, 2008 35.5 KB View HTML View PDF View XLS  
4 barrett, m james Jun 7, 2007 29.9 KB View HTML View PDF View XLS  
4 topper, james n Jul 30, 2007 33.5 KB View HTML View PDF View XLS  
4 barkas, alexander e Jun 6, 2007 33.5 KB View HTML View PDF View XLS  
3 canaan equity iii lp May 30, 2007 42.7 KB View HTML View PDF View XLS  
4 topper, james n Mar 10, 2008 36.5 KB View HTML View PDF View XLS  
3 frazier healthcare iv lp May 30, 2007 31.2 KB View HTML View PDF View XLS  
4 topper, james n Feb 6, 2008 36.8 KB View HTML View PDF View XLS  
4 topper, james n Jun 7, 2007 34.8 KB View HTML View PDF View XLS  
4 crowley, john f Apr 3, 2008 36.4 KB View HTML View PDF View XLS  
3 prospect venture partners ii lp May 30, 2007 40.2 KB View HTML View PDF View XLS  
4 crowley, john f Jul 8, 2008 32.0 KB View HTML View PDF View XLS  
4 crowley, john f Jun 6, 2008 36.9 KB View HTML View PDF View XLS  
4 topper, james n Feb 20, 2008 36.7 KB View HTML View PDF View XLS  
4 topper, james n Feb 28, 2008 31.8 KB View HTML View PDF View XLS  
4 patterson, matthew r Jun 18, 2008 33.4 KB View HTML View PDF View XLS  
Showing 361-380 of 458 Page: 1 ... 15 16 17 18 19 20 21 22 23  Previous 20 | Next 20

Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy